Abstract: During the transition from a slow to rapid depolarization rhythm, rate-dependent sodium channel blockade develops progressively and increases from beat to beat under procainamide but more abruptly under lidocaine. We investigated the consequences of such differences on the dynamic course and stability of reentrant tachycardias at their onset. Procainamide and lidocaine were infused to equipotent plasma concentrations in canines with three-day-old myocardial infarction. We measured the activation times (ms) and maximum slopes of negative deflections in activation complexes (absolute value: |-dV/dt max | in mV/ms) in 191 unipolar electrograms recorded from ischemically damaged subepicardial muscle during programmed stimulation inducing reentrant tachycardias. Procainamide caused a greater reduction in |-dV/dt max | than did lidocaine in the responses to basic stimulation, and it favored the occurrence of cycle length prolongation at tachycardia onset as the |-dV/dt max | decreased progressively in successive beats. This resulted in conduction block and tachycardia termination in three of eight preparations. In contrast, lidocaine caused a greater depression in |-dV/dt max | in response to closely coupled extrastimuli, but |-dV/dt max | remained constant or even improved thereafter, and none of the tachycardias terminated spontaneously under lidocaine (n = 9). However, the reentrant circuits remained spatially unstable, and lidocaine favored the occurrence of cycle length dynamics displaying constant or decreasing trends. This study supports the notion that cycle length dynamics at tachycardia onset are determined by the properties of the reentrant substrate and their pharmacological modulation.
Introduction
Induction of reentrant activity (by programmed stimulation) marks a transition from a relatively slow depolarization rate (sinus rhythm, responses to S1) to a relatively faster one (responses to extrastimuli, tachycardia). We reported that postinfarction ventricular tachycardias induced in humans and in canines display distinct patterns of cycle length variations at tachycardia onset (Vinet et al. 1996) . In particular, a progressive increase in cycle length from the early beats to later ones was associated with depression of excitability in the reentrant circuit, as evidenced by a decrease in the absolute value of the maximum negative slope of the intrinsic deflection of unipolar electrograms (Hélie et al. 2000) . We therefore investigated the interaction between the dynamic properties of reentrant substrates and kinetic properties of selected drugs.
Procainamide and lidocaine display higher affinity for inactivated sodium channels than for activated or rested ones (Sada et al. 1979; Hondeghem and Matsubara 1984) . Therefore, they act more selectively on partially depolarized tissue (Campbell et al. 1991 ) and display marked rate-dependent depressant effects on action potential upstroke in ischemia (Schmitt et al. 1988; Kay et al. 1989 ). However, procainamide's kinetics of interaction with the sodium channel are slow, to the point that cumulative effects are induced at relatively slow depolarization rates. In contrast, lidocaine displays very fast kinetics of interaction (Campbell 1983) , and its effects are already maximal in response to premature stimuli (Pallandi and Campbell 1988) .
Unlike lidocaine, procainamide affects potassium channel activity (reviewed by Yang et al. 2001) and it decreases the slope of the restitution curve of action-potential duration in canine ventricular muscle (Varro et al. 1987) , an effect possibly related to procainamide's stabilizing actions on reentrant activity (Kwan et al. 1998; Kim et al. 1999; Riccio et al. 1999) .
The aim of this study was to investigate, in canine preparations, the implications of procainamide and lidocaine's differential kinetic properties on the cycle length dynamics and stability of activation patterns at the onset of reentrant ventricular tachycardias.
Methods

Canine preparations of myocardial infarction and electrophysiologic study
All procedures followed the guidelines of the Canadian Council for Animal Care and were monitored by an institutional committee. The following has been reported in detail previously (Cardinal et al. 1988; Hélie et al. 2000) and will be described only briefly. Conditioned canines of either sex (23-35 kg) were anesthetized (induction: 25 mg/kg Na thiopental i.v., maintained with halothane 1%). Under aseptic conditions, a left thoracotomy was performed, and the left anterior descending (LAD) coronary artery was ligated at 1 cm from its origin. The chest was closed and postoperative care was administered (analgesia, antibiotherapy). Three days later, the canines were reanesthetized (Na thiopental, α-chloralose (100 mg/h i.v.)) and ventilated with room air. The ventricles were exposed and maintained at 37°C with an infrared light. A plaque-electrode comprising 191 recording contacts (2.6 mm interelectrode spacing) was fixed onto the anterior surface of the left ventricle, with its top border (thick edge line), running along the nearby segment of the LAD (inset in Fig. 1 ). Ventricular tachycardias terminating spontaneously or degenerating into fibrillation were induced by programmed stimulation (constant-current pulses of 3 ms duration and 3× threshold intensity) applied at the right or basal left ventricular margin of the ischemically damaged region. The train of basic stimuli (S1) was applied at the longest cycle length (~350 ms) overdriving sinus rhythm. Up to four extrastimuli (S2-S5) were applied (a fifth extrastimulus being used in a single preparation under basal conditions) at decrementing coupling intervals (5 ms steps). Sustained tachycardias were considered monomorphic when similar surface ECG (aVF) and unipolar electrogram morphologies were repeated in successive beats. The tachycardias were interrupted by rapid burst pacing (cycle length, 90-140 ms) when the arrhythmias exceeded 10-15 s in duration, and by DC shock when they degenerated into ventricular fibrillation.
Epicardial mapping
Ventricular tachycardias induced in 3-day-old infarct canine preparations are generated by reentry. After LAD occlusion, canine hearts present an antero-septal infarction characterized, in most cases, by survival of a subepicardial layer of muscle overlying necrotic tissue on the anterior left ventricular wall. Unipolar recording contacts (referenced to Wilson's central terminal measured with three limb leads) and an ECG lead (aVF) were connected to a computerized, multichannel recording system (Hélie et al. 2000) . The signals were amplified by programmable-gain analog amplifiers and converted to digital format (1000 samples·channel ). Data of 15.3 s duration were stored on hard disk, from which selected files were later retrieved for analysis.
In unipolar electrograms, a local activation complex is superimposed onto a field potential common to all neighboring electrodes. Two measurements were extracted for each beat from the electrograms recorded at each electrode site. (i) The maximum slope of the negative deflection in the activation complex (reported herein as its absolute value: |-dV/dt max |, in mV/ms) was determined by computing for each sampling point the potential difference between the preceding and the following sampling points and dividing by 2 ms (2× the sampling period) (Hélie et al. 2000) .
(ii) The local activation time was determined at the point of -dV/dt max with a value generally in excess of 0.5 mV/ms and was expressed (in ms) with reference to the earliest activation time determined under the plaque electrode. When |-dV/dt max | was <0.5 mV/ms and the electrogram did not display an "rs" morphology, it was considered that excitation did not occur at the corresponding recording site, as a result of inexcitability or conduction block. Electrograms displaying dynamic variations were those that either failed to display activation at least once in a seven-beat sequence or displayed beat-to-beat variations in activation time in excess of 10 ms.
All computer-selected events were verified on a video screen with an interactive program. Isochronal maps (10-ms interval) were computed automatically by linear interpolation. Lines of functional dissociation were drawn between adjacent sites showing abrupt differences in activation times of at least 40 ms and wave fronts propagating in opposite directions.
Pharmacological studies
The drugs were studied at equipotent plasma concentrations estimated from their previously documented effects on conduction velocity and maximum rate of depolarization of the intracellular action potential (Campbell 1983; Courtney 1980; Ehring and Hondeghem 1980; Toyama and Furuta 1983; Buchanan et al. 1985; Neto and Sperelakis 1985; Varro et al. 1985 Varro et al. , 1987 Pallandi and Campbell 1988) . Procainamide was administered at a low-dosage regimen (bolus of 8 mg/kg injected i.v. over 15 min, maintenance of 4 mg·kg -1 ·h -1 ) yielding plasma concentrations in the upper therapeutic range, and then at a higher dosage (second bolus of 8 mg/kg followed by 8 mg·kg -1 ·h -1 ). In separate experiments, lidocaine boluses of 2 mg/kg were followed by infusions at 4 mg·kg -1 ·h -1 (low), and then 8 mg·kg -1 ·h -1 , yielding plasma concentrations in the upper therapeutic range and higher, respectively. Measurements could not be made under the high dosage in five preparations (one in the procainamide group and four in the lidocaine group) because they did not remain hemodynamically stable. Only the low dose was studied in one of the two preparations in which only a nonsustained ventricular tachycardia was induced under the low dose of procainamide. Ventricular tachycardias were induced two to seven times under basal conditions (mean of four) and only two to three times at each drug dosage because of time limitations in the pharmacological studies. Similar protocols of programmed stimulation were used under basal conditions and repeated under treatment with either procainamide or lidocaine.
Data analysis
In monomorphic ventricular tachycardias displaying a progressive increase or a progressive decrease in cycle length after their induction by programmed stimulation, the trend was fitted to the following exponential function (of beat number): CL = CLs -Aexp-n/τ, where CLs is the cycle length at stabilization, A is the amplitude of relaxation from the earliest cycle length to CLs, and τ is the exponential rate constant representing the number of beats at which the cycle length is 74% of CLs (Vinet et al. 1996; Hélie et al. 2000) . Parameter A has a positive value in tachycardias displaying cycle length prolongation in early beats, whereas A has a Fig. 1 . Prolongation of activation times and depression of -dV/dt max in response to premature stimulation inducing reentrant activity in ischemically damaged myocardium. The upper trace (ECG lead aVF) shows that under basal conditions, programmed stimulation (S1-S3; F indicates fusion of sinus beats with S1) induced polymorphic beats (V1-V6), which stabilized into a sustained monomorphic tachycardia (from V7 onward). Activation times (upper maps showing isochronal lines drawn at 10-ms intervals) and dV/dt max (lower maps) were extracted from unipolar electrograms recorded from the anterior wall of the left ventricle, using an octagonal plaque electrode (inset). In the responses to S1 (panel A), a wave front swept across the recording area and conduction times were relatively longer in areas in which the |-dV/dt max | was <2 mV/ms (light shading). In the responses to S3 (panel B; S2-S3 = 120 ms), activation delay, inexcitability (dark shading), and dissociated activation (thick lines) occurred in association with decreased |-dV/dt max |. Ventricular tachycardia then occurred, which displayed a figure-of-eight isochronal pattern (panel C). The tachycardia cycle length stabilized at 140 ms, while the |-dV/dt max | remained at low values (V91: 1.0 ± 1.3 mV/ms).
negative value in tachycardias displaying a dynamic pattern of cycle length shortening. The data for the present study includes some of the baseline data from the previously published study (Hélie et al. 2000) .
All data were expressed as means ± SD. Comparisons were made using paired or unpaired Student's t tests. Analysis of variance (ANOVA) was used to analyze comparisons of |-dV/dt max | values in the responses to S1 versus the ones to premature stimuli (within factor: prematurity effect). ANOVA was also used for comparisons of the basal, low dose, and high dose |-dV/dt max | and tachycardia cycle length values (within factor: drug concentration) under lidocaine or procainamide (between factor). ANOVA was followed by standard post-hoc tests. Comparisons were considered as statistically significant when p < 0.05.
Results
Procainamide and lidocaine effects on the responses to programmed stimuli inducing reentrant patterns
As reported previously (Hélie et al. 2000) , |-dV/dt max | measured in the unipolar electrograms recorded from ischemically damaged muscle were relatively high in the responses to S1 (Fig. 1A , lower panel; Table 1 ) but significantly lower in the responses to the closely coupled premature stimuli inducing reentrant activity (Fig. 1B , lower panel; Table 1 ). This was associated with modifications of the activation sequence in which, typically, the activation delay and the number of inexcitable sites increased (Fig. 1B, dark shading) , especially in the areas displaying |-dV/dt max | < 2 mV/ms in the responses to S1 (light shading). Reentrant activity occurred in these areas during monomorphic ventricular tachycardias (Fig. 1C) .
In the procainamide group, measurements were repeated at the lower dosage (plasma level of 73 ± 26 µmol/L) in eight preparations, and also at the high dosage in six preparations (172 ± 67 µmol/L). The drug induced a reduction in the |-dV/dt max | in the responses to S1 (Table 1A; low: -29%, high: -32%) as well as an increase in the number of inexcitable sites (comparing Figs. 1A and 2A) . In the lidocaine group, measurements were made in nine preparations at the lower dosage (12 ± 2.1 µmol/L) and in five preparations at the high dosage (26 ± 4.4 µmol/L). In contrast to procainamide, lidocaine produced significantly less reduction in the |-dV/dt max | in the responses to S1 (Table 1B ; low: -6.8%, high: -18%; significant interaction between the group effect and prematurity effect in the ANOVA: p < 0.0001).
In the responses to closely coupled premature stimuli inducing tachycardias (S2-S4), procainamide induced little further depression of the |-dV/dt max | in comparison to basal conditions (Table 1A ; Fig. 2B ). In contrast, lidocaine produced marked |-dV/dt max | depression in the responses to S2-S4 (Table 1B) . Thus, procainamide affected the |-dV/dt max | in the responses to S1 with little extra effect in the responses to S2-S4, whereas lidocaine exerted a greater depressant effect on the |-dV/dt max | in the responses to S2-S4 than in the responses to S1 (significant interaction among all factors of the ANOVA, p < 0.0001).
The arcs of functional dissociation mapped during reentrant activity induced under basal conditions (Fig. 1C) were converted, under procainamide, into areas of inexcitability around which the reentrant impulse circulated (Fig. 2C) . The |-dV/dt max | values measured during the tachycardias induced under procainamide were smaller than under basal conditions (Table 2A ). The tachycardia cycle lengths were longer under procainamide than under basal conditions (Table 2A; low: +21%, high: +40%), an effect to which an increase in the reentrant path length as well as |-dV/dt max | depression may have contributed. Lidocaine produced less prolongation of tachycardia cycle length (Table 2B ; low: +12%, high: +20%) and induced |-dV/dt max | reductions only at the high dose. Because of the variability of cycle lengths among preparations, the difference in the magnitude of effects on this variable between the two drugs was borderline for statistical significance (Table 2 ; testing for significance of the interaction in the ANOVA yielding p = 0.065). Lidocaine increased the number of inexcitable sites in comparison with basal conditions but the beat-to-beat variability in conduction times and the number of inexcitable sites was greater under lidocaine than under procainamide (vide infra).
The conditions under which the tachycardias were induced under procainamide and lidocaine were, on the whole, similar to the ones under basal conditions with regard to the numbers of extrastimuli required for induction (median of two extrastimuli); however, the coupling intervals of the initiating beats were significantly changed under procainamide (218 ± 29 vs. 178 ± 42 ms under basal) but not under lidocaine (176 ± 41 vs. 198 ± 46 under basal) .
Procainamide effects on the dynamic properties of ventricular tachycardias
Sustained monomorphic ventricular tachycardias were induced in most preparations under procainamide (which caused stabilization of the polymorphic tachycardias seen under basal conditions in four preparations), and they all displayed a progressive increase in cycle length at tachycardia onset (Fig. 3A) . As illustrated in Fig. 4 , under basal conditions (panel A) as well as under procainamide (panel B, low dose) there was a trend for a progressive increase in cycle length (superimposed on beat-to-beat fluctuations) in the early beats of the tachycardia, with a greater magnitude of cycle length prolongation and a shorter time constant under procainamide. In all preparations, a reduction in the |-dV/dt max | between tachycardia onset and stabilization occurred consistently under procainamide (Table 2A ; difference in |-dV/dt max | between tachycardia onset and stabilization (∆)). Also, the magnitude of the cycle length prolongation was significantly greater under procainamide (range of 12-29 ms) than under basal conditions (range of 4-11 ms). Figure 4C shows that under the high dose, the ventricular tachycardia (similar morphology as in Figs. 4A and 4B) displayed an even longer cycle length and terminated spontaneously after only seven reentrant beats. This is one of the three preparations in which procainamide caused a conversion of sustained monomorphic ventricular tachycardias into nonsustained ones (Fig. 3A) . Abrupt cycle length prolongation was a common feature occurring prior to spontaneous termination. Figure 5 shows that, in the nonsustained tachycardia illustrated in Fig. 4C , the cycle length increased steeply from 272 to 300 ms in the series of six beats leading to the final one. Cycle length prolongation was associated with (i) |-dV/dt max | depression (from 3.3 ± 0.2 to 1.6 ± 0.2 mV/ms at 92 recording sites), (ii) a progressive increase in the number of inexcitable sites (Fig. 5 , dark shading in beats V3, V6, V7) and (iii) an increase in the maximal conduction delay between sites A and D. The association of tachycardia termination with progressive |-dV/dt max | depression is illustrated with selected electrograms recorded from sites A-C. The electrogram recorded from the site of latest activation (site D) displayed a deflection with a |-dV/dt max | of~0.5 mV/ms in V1-V6, which disappeared in V7 at tachycardia termination. Further depression of excitability and -dV/dt max under procainamide and modification of the reentrant pattern. In the same preparation as in Fig. 1 , sustained monomorphic ventricular tachycardia displaying a slightly modified ECG morphology and longer stabilized cycle length (200 ms) was induced under procainamide (high dose). In the responses to S1 (panel A), several areas displaying the |-dV/dt max | < 2 mV/ms under basal conditions became inexcitable under procainamide (dark shading), and the mean |-dV/dt max | was reduced to 1.1 ± 0.9 mV/ms. In the responses to S3 (panel B; S2-S3 = 200 ms), there was little further depression of |-dV/dt max |, but the maximum delay increased to 186 ms. Ventricular tachycardia occurred, displaying reentry around a central area of inexcitability. The cycle length stabilized at a longer cycle length of 200 ms (panel C, V67), as further depression of the |-dV/dt max | occurred between S3 (0.9 ± 0.7 mV/ms) and V67 (0.7 ± 0.7 mV/ms). 
Lidocaine effects on the dynamic properties of ventricular tachycardias
Lidocaine also caused stabilization of polymorphic ventricular tachycardias into sustained monomorphic ones (Fig. 3B) and similarly, reentrant activity occurred in areas with depressed |-dV/dt max |. Two tachycardias displayed cycle length prolongation at their onset under lidocaine as well as under basal conditions. However, the group of monomorphic tachycardias displaying constant cycle length became more prominent under lidocaine (Fig. 3B) . The |-dV/dt max | was further depressed from early to late beats among the tachycardias displaying cycle length prolongation, but this variable was stable among the ones displaying constant cycle length dynamics. Therefore, lidocaine did not cause an overall change in the |-dV/dt max | between the onset and later beats of the ventricular tachycardias (Table 2B , high dose, ∆).
Moreover, a dynamic pattern consisting of a decreasing cycle length at tachycardia onset ( Fig. 6 ; graph) emerged under lidocaine in two preparations (one at both the low and the high dose, and another at the high dose only). This type of pattern was not seen under basal conditions (or under procainamide). It was associated with a statistically significant improvement in the |-dV/dt max | (V8 and V9, 1.8 ± 1.3 mV/ms; vs. V63, 2.6 ± 1.8 mV/ms, and V64, 2.2 ± 1.6 mV/ms; n = 167 sites) and with a reduction in the number of inexcitable sites (V8, 29; V9, 32; vs. V63, 16, and V64: 10) . As reported previously (Hélie et al. 2000) , improvement of the |-dV/dt max | was associated with shortening of local conduction times (V9, 6.7 ± 6.1 ms/mm; V63, 5.7 ± 6.6 ms/mm). The |-dV/dt max | also improved in later beats in several tachycardias in which a pattern of constant cycle length occurred under the low dose of lidocaine (Table 2B , low dose, ∆). Figure 6 also illustrates the fact that, during the monomorphic tachycardias induced under lidocaine, marked beatto-beat variations occurred in the |-dV/dt max |, in the activation times and in the number of inexcitable sites (comparing V8-V9 and V63-V64). Such variations in the local conduction characteristics were detected at only 14 ± 9 sites in five tachycardias induced under basal conditions, increasing to 50 ± 36 sites under lidocaine in these preparations. The activation times measured at the other recording sites displayed beat-to-beat variations of only 2.5 ± 1.3 ms. A small number of unipolar electrograms recorded under lidocaine displayed even more complex variations that included alternations between excitation and inexcitability, and Wenckebach-type periodicities (three preparations). This is in contrast with observations made under procainamide after stabilization of the tachycardia cycle length, in which beat-to-beat variability was completely suppressed (variations of activation times of 2 ms or less).
Discussion
Temporal dynamic patterns
This study adds other arguments supporting our proposition that the tachycardia onset dynamics may be related to the electrical properties of reentrant substrates (Hélie et al. 2000) , since the tachycardia onset dynamics were affected in accordance with the known properties of the drugs under study. This study also supports the notion that the |-dV/dt max | of unipolar electrograms is a sensitive measure of depressed excitation properties. The lidocaine-induced depression of |-dV/dt max | was maximal in response to programmed stimulation, and this variable even improved in the early beats of the tachycardias in some preparations. Accordingly, there was a shift towards dynamic patterns displaying constant or decreasing cycle length. In contrast, procainamide caused the cycle length to increase in the initial beats of the tachycardia, as the |-dV/dt max | values were further depressed, leading to conduction block and spontaneous tachycardia termination in some preparations. All other tachycardias induced under procainamide were monomorphic and sustained and displayed a pattern of cycle length prolongation.
Procainamide is a relatively weak I Kr blocker (Yang et al. 2001 ) but causes minimal prolongation of the action-potential duration at high depolarization rate in healthy cardiac mus- Fig. 3 . Differential effects of procainamide and lidocaine on cycle length dynamics at tachycardia onset. The left hand column indicates the types of ventricular arrhythmias and the dynamic patterns of the sustained tachycardias. The right hand columns indicate the type and dynamic pattern of ventricular arrhythmias induced in each preparation under each experimental condition. As previously reported (Hélie et al. 2000) , the type and dynamic pattern were reproducible among several tachycardias repeatedly induced under each condition in a given preparation; therefore, a single representative point is shown for each preparation. (A) Procainamide favored the occurrence of sustained monomorphic tachycardias displaying cycle length prolongation at their onset, and it also converted sustained to nonsustained tachycardias. (B) Lidocaine also favored the induction of sustained monomorphic ventricular tachycardias, but their dynamic patterns were more variable and included trends of constant or decreasing cycle length.
cle (Dangman and Miura 1989; Campbell et al. 1991) . It is possible that in ischemically damaged muscle, changes in action-potential duration might have contributed to prolongation of refractory periods and to the progressive increase Cycle length prolongation at tachycardia onset and conversion to nonsustained tachycardia under procainamide. A similar tachycardia morphology (ECG lead aVF) was induced under basal conditions (A) and reinduced under procainamide at a low dose (B) and at a high dose (C; nonsustained tachycardia). The light lines show the actual data points, whereas the dark lines (in panels A and B) represent the trends consisting of a progressive increase in cycle length (generated by fitting the data to an exponential mathematical model, in which CLs is the cycle length after stabilization, A is the amplitude of the cycle length relaxation from the initial beats to stabilization, and τ is the exponential rate constant). Cycle length dynamics of a similar type (decelerating trend) occurred under basal conditions and under low-dose procainamide (although the initial cycle length and CLs were markedly increased in the latter). In panel A, the decelerating trend was associated with a statistically significant reduction of the |-dV/dt max | from 1.7 ± 0.4 to 1.1 ± 0.3 mV/ms, which occurred mainly at 22 recording sites displaying markedly depressed excitability (|-dV/dt max | <2.0 mV/ms). In panel B, the reentrant activity moved to less depressed tissue as the circuit size increased under procainamide (maps not shown); therefore, the cycle length prolongation was associated with a |-dV/dt max | reduction at 43 recording sites displaying moderately depressed |-dV/dt max | (early beat: 3.7 ± 0.5, stabilization: 2.9 ± 0.4 mV/ms). Under the high dose (C), cycle length prolongation occurring in the early beats was followed by spontaneous tachycardia termination and resumption of sinus rhythm (SR). The data presented in panel A (basal) were previously reported in greater detail (Hélie et al. 2000) .
in tachycardia cycle length under procainamide (Grenader and Zurabishvili 1985) in addition to the drug's depressant effects on the membrane active properties. Similar effects on tachycardia onset dynamics have been observed in patients. Kidwell et al. (1993) reported that when similar monomorphic ventricular tachycardias were induced under basal conditions and procainamide, this drug converted tachycardias displaying a constant cycle length into tachycardias displaying a progressively increasing cycle length. In contrast, any cycle length prolongation induced by lidocaine was achieved in the early beats.
Spatial dynamic patterns
The further depression of sodium channel activity induced in the presence of lidocaine and procainamide may have caused dynamic modifications in the anatomy of the circuits. This study reports evidence that procainamide, as well as lidocaine (see also Hélie et al. 1995) , converted polymorphic ventricular tachycardias into monomorphic ones and favored the occurrence of circus movement. In fact, isochronal patterns consistent with anisotropic reentrant activity were converted to reentrant patterns occurring around inexcitable areas under drug.
It has been claimed that procainamide could increase the cycle length as well as the core area of reentry, and prevent spontaneous wave break during ventricular fibrillation induced in healthy canines (Kim et al. 1999) . Stabilization of reentrant circuits is consistent with the data reported herein. Although we did not directly address procainamide effects on the restitution curve of repolarization intervals, prolongation of tachycardia cycle length under procainamide should have caused a shift towards the flat part of the restitution curve (Kim et al. 1999) .
After stabilization of the tachycardia cycle length, there was little beat-to-beat variation in the activation time and number of inexcitable sites under procainamide (i.e., variations were reduced in comparison with the ones occurring under basal conditions). In contrast, block in one area in a given beat could be followed by slow conduction in the same area in the next beat under lidocaine. As a consequence of these varying local conduction characteristics, the reentrant wave fronts could circulate around obstacles of inexcitable tissue that developed along their course, thereby avoiding spontaneous termination under lidocaine. There were also instances in which the cycle length decreased in successive beats under lidocaine (a dynamic pattern that did not occur either under basal conditions or under procainamide). Such acceleration of the tachycardia could have been caused by a decrease in the circuit length and improvement of the |-dV/dt max | of unipolar electrograms (with a concurrent improvement of conduction velocity in critical parts of the circuit) as illustrated in Fig. 6 . One mechanism possibly explaining this effect might be a frequency-dependent decrease in action-potential duration, thereby causing the reentrant Fig. 6 . Cycle length shortening at tachycardia onset and beat-to-beat variations in local conduction characteristics under lidocaine. The upper graph shows the course of the tachycardia cycle length in successive beats (light lines, actual data points; dark line, trend generated by fitting the data to an exponential mathematical model in which CLs is the cycle length after stabilization, A is the amplitude of the cycle length relaxation from the initial beats to stabilization, and τ is the exponential rate constant). A sustained ventricular tachycardia displaying cycle length shortening was induced under lidocaine (high dose). The upper and lower maps show activation times and -dV/dt max values, respectively, for an early (V8 and V9) and late (V63 and V64) pair of consecutive beats. The wave fronts circulated around inexcitable areas (dark shading) in areas in which the -dV/dt max was <2.0 mV/ms (light shading) or 2.0 mV/ms (clear). The size of the areas of inexcitability became smaller, and the dV/dt max improved at most recording sites, as the tachycardia cycle length shortened from the early to the later beats. Note also the beat-to-beat variations in local conduction characteristics between V8 and V9, as well as between V63 and V64.
wave front to withdraw from the refractory tail of the previous activation cycle in selected areas.
The analyses reported herein show that the dynamic course and stability of reentrant ventricular tachycardias are differentially affected by drugs with distinct properties, and support the notion that cycle length dynamics at tachycardia onset are determined by the properties of the reentrant substrate.
